Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Cattle vaccination will not work on its own
AHVLA scientists comment on TB vaccine

Cattle vaccination against bovine tuberculosis could offer farmers an important tool to help prevent TB infection in their herds, but it will not wipe out the disease completely.

Glyn Hewinson, chief scientist at the Animal Health and Veterinary Laboratories Agency (AHVLA), commented that he did not think that cattle vaccination "can be a strategy on its own - you have to use all the tools in your toolbox," but he added that "the level of investment that's going into the development of TB vaccines shows the commitment to develop these important tools to control TB in the UK."

Defra has budgeted £15.5 million for research into developing effective cattle TB vaccines over the next four years, and the AHVLA has developed a blood test - a DIVA test - which can distinguish between infected and vaccinated animals.

Defra is currently working with the EU to change legislation to allow a BCG cattle vaccine and the DIVA to be used in combination to tackle bovine TB, with the aim of allowing both to be used legally in the UK.

However, Defra secretary Owen Paterson has insisted that vaccination is still not a viable alternative to badger culling. Speaking at a meeting of the Conservative Rural Affairs Group, in Birmingham, he said that currently, vaccines are "not yet in a position to be deployed" in either cattle or badgers.

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.